Case Evaluation

Avandia: Avandia Clinical Trials - Adverse Effects - Serious Adverse Events

Serious Adverse Events (SAEs) On Therapy (update, Jul 2005) - includes both fatal and non-fatal events. Related events include those categorized as Not Assessable, Possible, Probable, Unknown, Unlikely, or Not recorded.
n (%) [related]
Subjects with any SAEs
299 (1.31) [85]
Dyspnoea
21 (0.09) [16]
Angina pectoris
19 (0.08) [9]
Cerebrovascular accident
18 (0.08) [4]
Myocardial infarction
17 (0.07) [8]
Cardiac failure
16 (0.07) [13]
Cardiac failure congestive
12 (0.05) [6]
Coronary artery disease
11 (0.05) [3]
Pulmonary oedema
8 (0.04) [7]
Chest pain, pulmonary embolism
8 (0.04) [3]
Circulatory collapse
8 (0.04) [1]
Gangrene, pancreatic carcinoma
7 (0.03) [0]
Hypoglycemia
6 (0.03) [6]
Hemiparesis
6 (0.03) [4]
Pleural effusion
6 (0.03) [3]

Dangerous Drug Case Evaluation

* First Name:
* Last Name:
* Zipcode:
* E-Mail:
* Phone:
Okay to call you at this number?
Yes No
Enter any relevant background information or case specifics so that we can best understand your situation:
To Prevent Automated Submissions, Enter the 4 Digit Number Shown Below
(OR YOU MAY CALL US DIRECTLY AT 888-375-7600)
1249

Dangerous Drug Topics

Dangerous Drug Videos

Dangerous Drug Links

Product Liability Resources